Expression changes of IL-17 in zoledronic acid combined with PVP technology in the treatment of postmenopausal osteoporotic vertebral compression fracture and its predictive value of relapse

OBJECTIVE: To investigate the expression of interleukin-17 (IL-17) in zoledronic acid combined with PVP technology for patients with postmenopausal osteoporotic vertebral compression fracture (OVCF) and its predictive value for relapse. METHODS: 101 OVCF patients treated in our hospital from April 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Linsong, Liu, Yao, Nazierhan, Shaxika, Sun, Zhiguo, Aikeremu, Dilimulati, Alimasi, Wuqikun, Xu, Kuo, Niyazi, Waresijiang, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716692/
https://www.ncbi.nlm.nih.gov/pubmed/33265085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716692/
https://www.ncbi.nlm.nih.gov/pubmed/33265085

Ejemplares similares